sign in · help · news · about ·

BibSonomy :: user :: kanefendt ::

tag user group author concept BibTeX key search:all search:kanefendt

The blue social bookmark and publication sharing system.

>
|
<

bookmarks

bookmarks per page: 5 10 20 50 100

RSS BibTeX RDF more

publications

(15)

<< < 1 > >>

VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment
A. Gampel, L. Moss, M. C. Jones, V. Brunton, J. C. Norman, and H. Mellor Blood 108(8):2624-2631 (2006)
to A Active Adult Biological Blood Cell Cells Compartmentation Cultured Endosomes Endothelial Factor GTP-Binding Growth Humans Kinases Laboratories Lysosomes Membrane Plasma Proteins Receptor-2 Recombinant Research Transport Tyrosine Vascular Vessels blood cells cytology drug effects metabolism pharmacology protein rab4 response src-Family by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis
A. Y. Debrah, S. Mand, S. Specht, Y. Marfo-Debrekyei, L. Batsa, K. Pfarr, J. Larbi, B. Lawson, M. Taylor, O. Adjei, and A. Hoerauf PLoS.Pathog. 2(9):e92 (2006)
to & Adult Aged Animals C Data Doxycycline Elephantiasis Endothelial Factor Female Filarial Filaricides Growth Humans Hydrocele Intercellular Lymphatic Lymphedema Male Microfilaria Middle Molecular Outcome Parasitemia Peptides Plasma Proteins Receptor-3 Research Sequence Signaling System Testicular Testis Treatment Vascular Vessels Wolbachia and antagonists blood drug effects immunology inhibitors isolation parasitology pathology physiology protein purification therapeutic therapy ultrasonography use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap
F. T. Wu, M. O. Stefanini, Gabhann F. Mac, and A. S. Popel PLoS.One. 4(4):e5108 (2009)
to A Binding Biological Biology Capillaries Dimerization Endothelial Factor Growth Human Humans Ligands Lymphatic Models Muscle Plasma Receptor-1 Research Skeletal States Systems Tyrosine United Vascular Vessels metabolism physiology protein therapy ultrastructure by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
N. Murukesh, C. Dive, and G. C. Jayson Br.J.Cancer (2009)
to Blood Growth Health Medical Oncology Plasma Pressure Prospective Research Studies blood identify response by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Soluble angiogenesis markers in gastric tumor patients
P. Mysliwiec, K. Pawlak, R. Bandurski, and B. Kedra Folia Histochem.Cytobiol. 47(1):81-86 (2009)
to A Adult Aged Antigens Biological CD Care Case-Control Cell Endothelial Factor Female Growth Human Humans Male Markers Middle Neoplasms Neovascularization Pathologic Plasma Preoperative Receptor-2 Receptors Solubility Stomach Studies Surface Tumor Vascular blood metabolism protein supply surgery by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
H. J. Burstein, A. D. Elias, H. S. Rugo, M. A. Cobleigh, A. C. Wolff, P. D. Eisenberg, M. Lehman, B. J. Adams, C. L. Bello, S. E. Deprimo, C. M. Baum, and K. D. Miller J Clin Oncol 26(11):1810-1816 (2008)
to & Administration Adult Aged Agents Anthracyclines Antineoplastic Biological Breast Bridged Carcinoma Chemotherapy Combined Compounds Diseases Drug Fatigue Female Gastrointestinal Growth Hematologic Humans Indoles Inflammation Kinase Kinases Markers Middle Neoplasms Oral Plasma Protein-Tyrosine Protocols Pyrroles Rate Schedule Survival Taxoids Tumor Tyrosine administration adverse analysis antagonists blood chemically classification dosage drug effects induced inhibitors methods mortality response secondary therapeutic therapy use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors
F. A. Eskens, N. Steeghs, J. Verweij, J. L. Bloem, O. Christensen, Doorn L. van, J. Ouwerkerk, M. J. Jonge, J. W. Nortier, J. Kraetzschmar, P. Rajagopalan, and H. Gelderblom J.Clin.Oncol. 27(25):4169-4176 (2009)
to & A Administration Adolescent Adult Aged Angiogenesis Biological Contrast Dose Dose-Response Drug Endothelial Factor Factors Fatigue Female Growth Human Humans Hypertension Imaging Inhibitors Kinase Magnetic Male Markers Maximum Media Medical Metastasis Middle Neoplasm Neoplasms Oncology Oral Outcome Pharmacokinetics Plasma Platelet-Derived Protein Proteins Proto-Oncogene Pyridazines Pyridines Receptor Receptor-2 Receptor-3 Relationship Research Resonance Safety Schedule Time Tolerated Treatment Tumor Tyrosine Vascular Young administration adverse antagonists beta blood c-kit diagnostic dosage drug effects enzymology inhibitors methods pathology protein response supply therapy toxicity use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
L. F. Kontovinis, K. T. Papazisis, P. Touplikioti, C. Andreadis, D. Mouratidou, and A. H. Kortsaris BMC.Cancer (2009)
to Carcinoma Gastrointestinal Medical Oncology Plasma Population Stromal Tumors Tyrosine analysis methods protein response by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Phase I dose escalation study of telatinib BAY 57-9352 in patients with advanced solid tumours
D. Strumberg, B. Schultheis, I. A. Adamietz, O. Christensen, M. Buechert, J. Kraetzschmar, P. Rajagopalan, M. Ludwig, A. Frost, S. Steinbild, M. E. Scheulen, and K. Mross Br.J.Cancer 99(10):1579-1585 (2008)
to & 80 Adult Aged Agents Angiogenesis Antineoplastic Carcinoma Dose Female Growth Humans Hypertension Imaging Inhibitors Magnetic Male Maximum Medical Middle Neoplasms Oncology Plasma Pyridazines Pyridines RANGE Resonance Tolerated Tyrosine administration and blood dosage drug over response therapy by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
M. L. George, S. A. Eccles, M. G. Tutton, A. M. Abulafi, and R. I. Swift Clin.Cancer Res. 6(8):3147-3152 (2000)
to 80 A Adult Aged Blood Colorectal Count Endothelial Factor Factors Female Growth Humans Lymphokines Male Middle Neoplasm Neoplasms Plasma Platelet Platelets Staging Vascular and blood cytology over pathology physiology supply surgery by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood
E. Gunsilius, A. Petzer, G. Stockhammer, W. Nussbaumer, P. Schumacher, J. Clausen, and G. Gastl Oncology 58(2):169-174 (2000)
to A Adult Aged Blood Count Endothelial Factor Factors Growth Human Humans Lymphokines Middle Neoplasms Plasma Platelet Plateletpheresis Platelets Prognosis Vascular blood metabolism pathology by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma
J. M. Ebos, G. Bocci, S. Man, P. E. Thorpe, D. J. Hicklin, D. Zhou, X. Jia, and R. S. Kerbel Mol.Cancer Res. 2(6):315-326 (2004)
to Animals Antibodies Binding Cell Cells Chemistry Conditioned Culture Endothelial Factor Factors Glycosylation Growth Health Human Humans Immunoprecipitation Line Media Mice Molecular Plasma Protein Receptor-2 Research Solubility Tyrosine Vascular Weight blood cells immunology metabolism protein secretion by kanefendt and 1 other user on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Determination of vascular endothelial growth factor VEGF in circulating blood: significance of VEGF in various leucocytes and platelets
K. Werther, I. J. Christensen, and H. J. Nielsen Scand.J.Clin.Lab Invest 62(5):343-350 (2002)
to 80 A Adult Aged Blood Chemistry Coagulation Colorectal Count Endothelial Factor Factors Female Growth Humans Immunomagnetic Intercellular Leukocytes Lymphocytes Lymphokines Male Middle Monocytes Neoplasms Peptides Plasma Platelet Platelets Proteins Research Separation Signaling Time Vascular Whole analysis and blood cells immunology methods over protein by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma
K. Werther, I. J. Christensen, and H. J. Nielsen Br.J.Cancer 86(3):417-423 (2002)
to 80 A Adult Aged Biological Carcinoma Colonic Colorectal Endothelial Factor Factors Female Growth Humans Lymphokines Male Markers Middle Neoplasm Neoplasms Plasma RANGE Rate Rectal Reference Research Staging Survival Time Tumor Values Vascular and blood mortality over pathology surgery by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
A critical review of vascular endothelial growth factor VEGF analysis in peripheral blood: is the current literature meaningful?
E. Hormbrey, P. Gillespie, K. Turner, C. Han, A. Roberts, D. McGrouther, and A. L. Harris Clin.Exp.Metastasis 19(8):651-663 (2002)
to A Blood Collection Count Endothelial Factor Factors Growth Hematocrit Humans Intercellular Lymphokines Neovascularization Pathologic Peptides Physiologic Plasma Platelet Prognosis Proteins Research Signaling Specimen Temperature Vascular analysis and blood methods protein by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)

<< < 1 > >>publications per page: 5 10 20 50 100

a gripper